CME Group (CME) Tops Q4 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Citi on CME Group (CME): 'We remain constructive on the stock'
February 14, 2024 7:49 AM ESTCiti analyst Chris Allen reiterated a Buy rating and $240.00 price target on CME Group (NASDAQ: CME)
The analyst comments "CME reported 4Q23 adj. EPS of $2.37 (vs our est/consensus of $2.30/2.28). Revenue came in above our expectations at $1.44B (vs est. of $1.42B), with... More



